Macrophages in neovascular age-related macular degeneration: friends or foes?
- PMID: 18600240
- PMCID: PMC8204908
- DOI: 10.1038/eye.2008.206
Macrophages in neovascular age-related macular degeneration: friends or foes?
Abstract
The events that lead to choroidal neovascularization in eyes with age-related macular degeneration are poorly understood. One possibility that has been explored in a number of studies is that macrophages can promote neovascular changes. In this paper, we summarize the evidence for inflammation in general and macrophages in particular in pathologic neovascularization, and discuss how the diverse functions of these cells may promote or inhibit macular disease. We also discuss some of the conflicting findings regarding the role of macrophages in experimental choroidal neovascularization in mouse models, and suggest areas for future research.
Figures
References
-
- Klein R, Klein B, Cruickshanks K. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res. 1999;18:371–89. - PubMed
-
- Buch H, Vinding T, Nielsen N. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology. 2001;108:2347–57. - PubMed
-
- Smith W, Assink J, Klein R, Mitchell P, Klaver C, Klein B, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697–704. - PubMed
-
- Friedman D, O'Colmain B, Munoz B, Tomany S, McCarty C, deJong P, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72. - PubMed
-
- VanNewkirk M, Nanjan M, Wang J, Mitchell P, Taylor H, McCarty C. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology. 2000;107:1593–600. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
